Kate Young

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 7

Top Topics

Endometrial Cancer

Advanced Non Small Cell Lung Cancer

Mesenchymal Stem Cells

Top Venues

Journal of medical economics

This page only lists publications with an associated author ORCID identifier.

Publications

Grant McCarthy, Kate Young, Matthew Madin-Warburton, Tyler Mantaian, Elizabeth Brook, Kaylie Metcalfe, Jan Mikelson, Ruifeng Xu, Carl Seyla-Hammer, Raquel Aguiar-Ibáñez, Mayur Amonkar
Cost-effectiveness of pembrolizumab for previously treated MSI-H/dMMR solid tumours in the UK. Journal of medical economics 27 (1) (2024)
Lewis Ralph, Kate Young, Navneet Upadhyay, Vimalanand Shrikant Prabhu, Christina Ljungcrantz, Rachid Massaad, Ruifeng Xu, Anna Giertz, Adil Merchant, Robert Orlowski, Linda Duska
Cost effectiveness of pembrolizumab plus lenvatinib compared with chemotherapy for treating previously treated advanced endometrial cancer in Sweden. Journal of medical economics 27 (1) (2024)
Lewis Ralph, Kate Young, Navneet Upadhyay, Vimalanand Shrikant Prabhu, Christina Ljungcrantz, Rachid Massaad, Ruifeng Xu, Anna Giertz, Adil Merchant, Robert Orlowski, Linda Duska
Cost effectiveness of pembrolizumab plus lenvatinib compared with chemotherapy for treating previously treated advanced endometrial cancer in Sweden. Journal of medical economics 27 (1) (2024)
Grant McCarthy, Kate Young, Matthew Madin-Warburton, Tyler Mantaian, Elizabeth Brook, Kaylie Metcalfe, Jan Mikelson, Ruifeng Xu, Carl Seyla-Hammer, Raquel Aguiar-Ibáñez, Mayur Amonkar
Cost-effectiveness of pembrolizumab for previously treated MSI-H/dMMR solid tumours in the UK. Journal of medical economics 27 (1) (2024)
Grant McCarthy, Kate Young, Matthew Madin-Warburton, Tyler Mantaian, Elizabeth Brook, Kaylie Metcalfe, Jan Mikelson, Ruifeng Xu, Carl Seyla-Hammer, Raquel Aguiar-Ibáñez, Mayur Amonkar
Cost-effectiveness of pembrolizumab for previously treated MSI-H/dMMR solid tumours in the UK. Journal of medical economics (2024)
Lewis Ralph, Kate Young, Navneet Upadhyay, Vimalanand Shrikant Prabhu, Christina Ljungcrantz, Rachid Massaad, Ruifeng Xu, Anna Giertz, Adil Merchant, Robert Orlowski, Linda Duska
Cost effectiveness of pembrolizumab plus lenvatinib compared with chemotherapy for treating previously treated advanced endometrial cancer in Sweden. Journal of medical economics 27 (1) (2024)
Lewis Ralph, Kate Young, Navneet Upadhyay, Vimalanand Shrikant Prabhu, Christina Ljungcrantz, Rachid Massaad, Ruifeng Xu, Anna Giertz, Adil Merchant, Robert Orlowski, Linda Duska
Cost effectiveness of pembrolizumab plus lenvatinib compared with chemotherapy for treating previously treated advanced endometrial cancer in Sweden. Journal of medical economics (2024)